Search results

COVID-19: Employment and Incentives issues The COVID-19 pandemic has transformed the employment landscape in a matter of days. As employers strive to come to terms with the outbreak, this briefing provides an overview of the key legal issues for employers to consider.     Coronavirus: Beware opportunistic claims of Force Majeure As a result of the COVID-19 outbreak, a number of companies are considering their legal options, and we are advising on an increasing number of asserted force majeure claims. In addition to its toll on human lives, the outbreak of COVID-19 coronavirus is... AGMs and impact of COVID-19 This note gives guidance on ways for companies to prepare for their 2020 AGMs as the spread of the COVID-19 virus is raising a number of issues to consider.  As companies prepare for their 2020 AGMs, the spread of the COVID-19 virus is raising a num... What should you do to combat the new COVID-19 cyber risk? Organisations grappling with a variety of issues raised by the coronavirus should ensure that ‘increased cyber risk’ is on the list of new risks to manage. Treasury: COVID-19 Health Check Overview and insight on the most frequent questions and challenges faced by corporate treasuries related to the COVID-19 crisis.  In this note, we provide an overview of some of the most frequent questions and challenges we have dealt with as the si... The wolf in sheep’s clothing? The consequences of the CMA asserting broad jurisdiction over global mergers So far, 2020 has seen the UK Competition and Markets Authority (CMA) continue to take an increasingly interventionist approach to global deals, including those with little to no UK nexus, pushing the boundaries of its jurisdiction. As this briefing expla... HR Budget Briefing 2020 Whilst the Government’s proposed response to coronavirus may have grabbed most of the immediate headlines, the UK 2020 Budget also included a number of other significant changes affecting employees’ pay and pension arrangements. In this remune... Competition & Regulatory Newsletter On 4 March 2020 the Competition and Markets Authority announced its decisions to fine four pharmaceutical companies for breaking competition law. The CMA's investigation into the suppliers of the antidepressant drug nortriptyline has resulted in fines... Getting it done: the UK's March 2020 Budget Whilst the Budget was dominated by the announcement of a multi-billion pound economic stimulus to deal with the economic impact of Covid-19, a whole range of other spending and tax measures (some with immediate effect and others subject to consultati... EFIG: European Banking Newsletter - March 2020 Developments covered in this month’s edition include: Transition from EONIA to €STR - ECB publishes working group report on the transfer of liquidity for cash and derivatives products Climate change and the financial sector - sp...